TetraLogic Pharmaceuticals Corporation
TLOG
$0.00
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | 09/30/2015 | |
|---|---|---|---|---|---|
| Net Income | 14.08% | 6.21% | -11.08% | -38.28% | -54.51% |
| Total Depreciation and Amortization | -16.13% | 13.87% | 41.78% | 49.13% | 95.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.28% | 44.17% | 29.71% | 116.02% | 57.27% |
| Change in Net Operating Assets | 223.87% | 209.09% | 2,819.32% | 138.46% | -364.14% |
| Cash from Operations | 35.47% | 22.62% | -0.35% | -7.80% | -55.95% |
| Capital Expenditure | 99.62% | 85.78% | 77.46% | 84.97% | 57.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.48% | 113.97% | 5,338.25% | 187.47% | 171.70% |
| Cash from Investing | -59.82% | 119.15% | 311.98% | 165.67% | 155.88% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | -100.00% | 4,070.16% | 1,831.67% | 1,200.35% | -94.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 438.86% | -94.05% | -95.96% | -98.17% |
| Foreign Exchange rate Adjustments | 136.29% | 53.08% | -173.47% | -72.46% | -454.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -802.85% | 86.47% | 35.16% | 105.30% | -107.62% |